View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Psoriatic Disease News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 26, 2024
2 min read
Save

Bimekizumab results in rapid, sustained improvements to PsA patient reported outcomes

Bimekizumab results in rapid, sustained improvements to PsA patient reported outcomes

Bimekizumab treatment for psoriatic arthritis demonstrated rapid, clinically meaningful improvements to patient reported outcomes that were sustained up to 1 year, according to data published in Rheumatology.

SPONSORED CONTENT
June 17, 2024
4 min read
Save

Treatment advancements merit updates to dermatological disqualifiers in the military

Treatment advancements merit updates to dermatological disqualifiers in the military

Due to medical advancements, researchers are calling for an update to the U.S. Department of Defense’s policies restricting individuals with psoriasis and atopic dermatitis from joining and remaining in the military, according to a study.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
June 12, 2024
2 min read
Save

Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis

Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis

Difficult-to-treat psoriatic arthritis was common in a large, real-life cohort, with key risk factors including extensive psoriasis, higher BMI and a history of inflammatory bowel disease, according to data published in Rheumatology.

SPONSORED CONTENT
June 06, 2024
2 min read
Save

Targeted psoriatic arthritis therapies demonstrate low risk for serious infection

Targeted psoriatic arthritis therapies demonstrate low risk for serious infection

Serious infections were uncommon among patients with psoriatic arthritis exposed to targeted therapies for the first time in “a large and exhaustive” French cohort, according to data published in RMD Open.

SPONSORED CONTENT
June 06, 2024
2 min watch
Save

VIDEO: Dermatologists, rheumatologists share care in psoriasis, psoriatic arthritis

VIDEO: Dermatologists, rheumatologists share care in psoriasis, psoriatic arthritis

CLEVELAND — Dermatology and rheumatology often work together in the treatment of psoriasis and psoriatic arthritis.

SPONSORED CONTENT
June 04, 2024
1 min read
Save

FDA approves Rinvoq for JIA, psoriatic arthritis in children aged 2 years and older

FDA approves Rinvoq for JIA, psoriatic arthritis in children aged 2 years and older

The FDA has expanded the indication of Rinvoq to include active, polyarticular juvenile idiopathic arthritis and psoriatic arthritis in children aged 2 years and older, according to an AbbVie press release.

SPONSORED CONTENT
June 02, 2024
1 min watch
Save

With abundant psoriasis treatments available, research now aiming for higher goals

With abundant psoriasis treatments available, research now aiming for higher goals

CLEVELAND — With myriad treatment options now available for psoriasis vulgaris, recent research is focusing on reaching higher goals, Anthony P. Fernandez, MD, PhD, said at the Medical Dermatology Therapy Update III meeting.

SPONSORED CONTENT
May 28, 2024
1 min read
Save

Stress may be associated with increased risk of psoriasis among men

Stress may be associated with increased risk of psoriasis among men

Low stress resilience in men may be linked to an increased risk for developing psoriasis or psoriatic arthritis, according to a study.

SPONSORED CONTENT
May 24, 2024
4 min read
Save

IL-17 inhibitors may break TNFi ‘glass ceiling’ in psoriatic arthritis prescribing

IL-17 inhibitors may break TNFi ‘glass ceiling’ in psoriatic arthritis prescribing

Although TNF inhibitors remain the first choice biologic for many rheumatologists treating psoriatic arthritis, interleukin-17 inhibitors may soon overtake them, according to a market analysis from Spherix Global Insights.

SPONSORED CONTENT
May 23, 2024
1 min read
Save

Simlandi launches in U.S. as third interchangeable Humira biosimilar

Simlandi launches in U.S. as third interchangeable Humira biosimilar

Simlandi injection, an interchangeable biosimilar to Humira, is now available in the U.S. for the treatment of psoriatic arthritis, plaque psoriasis and other conditions, Teva Pharmaceuticals and Alvotech announced in a press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails